How Synthetic DNA Can Help Combat Antibiotic Resistance

Posted by Nat Connors on 11/30/16 11:30 AM

Antibiotic resistance is a growing problem in our world. Devin Leake, Vice President of Research and Development at Gen9, weighs in on how synthetic biology--and specifically long-length synthetic DNA constructs--can combat the issue of antibiotic resistance.

Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

Gen9 Named #31 on  Biofuels Digest  List of 40 Hottest Emerging Companies

Posted by Nat Connors on 11/22/16 2:24 PM

Earlier this month, Gen9 was named #31 on Biofuels Digest’s list of the top 40 Hottest Emerging Companies in the Advanced Bioeconomy. The "Hot 40" companies were determined by voters and international panelists. Since 2008, over 100,000 individual company ratings have been evaluated in the annual contest, which recognizes smaller, emerging companies founded in the past 7 years.

Read More

Topics: Synthetic Biology

G-Prize Check-in: How Industrial Microbes Used 500kb of Synthetic DNA

Posted by Nat Connors on 11/15/16 11:00 AM
We caught up with Noah Helman, co-founder and Chief Scientific Officer at Industrial Microbes, to learn how the company has utilized the 500kb of synthetic DNA that the company was awarded in the 4th Annual G-Prize competition for synthetic biology.
Read More

Topics: Synthetic Biology, G-Prize, DNA Synthesis

Getting to Breakthroughs Faster with Mass Quantities of Synthetic DNA

Posted by Nat Connors on 8/11/16 10:03 AM
In this video, Patrick Boyle, Head of Design at Ginkgo Bioworks, discusses how mass quantities of synthetic DNA speed his design-build-test cycles and how long-length DNA constructs open up design possibilities in synthetic biology research.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

SynBio Conversations: Sajith  Wickramasekara, Benchling (Part 2)

Posted by Nat Connors on 8/9/16 9:57 AM

As part of our continuing synthetic biology conversations series, we spoke with Saji Wickramasekara, Founder and CEO of Benchling, a San Francisco-based company working to make life science research faster and more collaborative. The following is part two of our two-part conversation with Saji.

Read More

Topics: Synthetic Biology, DNA Design, Benchling

SynBio Conversations: Sajith Wickramasekara, Benchling (Part 1)

Posted by Nat Connors on 8/4/16 3:30 PM

As part of our continuing synthetic biology conversations series, we spoke with Saji Wickramasekara, Founder and CEO of Benchling, a San Francisco-based company working to make life science research faster and more collaborative. The following is part one of our two-part conversation with Saji.

Read More

Topics: Synthetic Biology, DNA Design, Benchling

The Power of DNA Synthesis: A Video

Posted by Nat Connors on 7/6/16 3:51 PM

A few weeks back, we announced that we'd signed a partnership with Ginkgo Bioworks to deliver 300 million base pairs of DNA through 2017. This unprecedented deal has been thought-provoking in many ways, and we’ve had some great questions arise from the synbio community and beyond. What will Ginkgo do with 300 megabases of content? How can Gen9 manufacture all that DNA? What could I do with pathway-length constructs like the ones Ginkgo uses?

We sat down with leaders at Ginkgo and Gen9 to learn more about what the partnership means for the future of synthetic biology.

Read More

Topics: Synthetic Biology, Gene Synthesis, Clonal, DNA Synthesis, DNA Design

300 Million Base Pairs and The Impact on The Synthetic Biology Industry

Posted by Kevin Munnelly on 6/8/16 2:30 PM

Earlier today, we announced some exciting news for the field of synthetic biology. We’re teaming up with Ginkgo Bioworks to supply 300 million base pairs of synthetic DNA between now and the end of 2017.  In this unprecedented deal, we will provide Ginkgo with massive quantities of pathway-length DNA constructs for use in their organism engineering platform.

Read More

Topics: Synthetic Biology

Why the Next Generation of our BioFab® Technology Changes the Game in Gene Synthesis

Posted by Andrew Bond on 4/1/16 3:40 PM

Last week, we announced the next generation of our BioFab® technology, an advancement that enables us to manufacture mass quantities of high quality, long-length, clonal DNA at prices as low as 3 cents per base pair. These game-changing economics will open doors for industrial users as they utilize megabase quantities of DNA on their journey towards new product discovery.

Read More

Topics: Synthetic Biology, Gene Synthesis, Multiplex, DNA Synthesis

Gen9ers Series: Brian Schneider

Posted by Nat Connors on 3/31/16 10:05 AM
Each month, we'll introduce you to a member of the extraordinary Gen9 team, or our Gen9ers (as we affectionately refer to our community). Today, you'll meet Brian Schneider, Director of Strategic Accounts for the Eastern United States. Brian joined the Gen9 team in August of 2015.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

Start the Conversation

Gen9's Blog

Founded by pioneering scientists in fabrication, genetics, and bio-engineering, the Gen9 vision is one of democratizing synthetic biology. Our goal is to enable broad adoption of powerful synthetic biology techniques by providing custom DNA constructs of the highest possible quality. 

This blog will serve as a platform to:

  • Educate our readers about the goings-on at Gen9
  • Keep our followers up-to-date with service updates and product enhancements
  • Share our views on current events in the Synthetic Biology world

Subscribe to Email Updates